Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics

12 Dec 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Epilepsy research and treatment
Share to Glioma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29234914
DOI: 10.1007/s00330-017-5182-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metricsPMID 29234914Read ↗

Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade GliomaSemantic proximity Read ↗

Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.Semantic proximity Read ↗

Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.Semantic proximity Read ↗

Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysisSemantic proximity Read ↗

Multicenter validation of amide proton transfer imaging for the classification of adult-type diffuse gliomas.Semantic proximity Read ↗

Prediction of O-6-methylguanine-DNA methyltransferase and overall survival of the patients suffering from glioblastoma using MRI-based hybrid radiomics signatures in machine and deep learning frameworkSemantic proximity Read ↗

Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.Semantic proximity Read ↗

Radiogenomic Prediction of MGMT Promoter Methylation Status in Glioblastoma Using Multi-Modal MRI and EfficientNetSemantic proximity Read ↗

Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.Semantic proximity Read ↗

Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity imageSemantic proximity Read ↗

Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysisSemantic proximity Read ↗

Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.